Medical Procedure News

RSS

ECRI Institute's recommendations for controlling CT radiation dose

The benefits of computed tomography (CT) have increased greatly over the past decade. Now twice as powerful, it offers dynamic images of anatomy, including the beating heart. Future advancements promise to deliver even more clinical benefits. However, CT has always had a downside: it can deliver high radiation doses to patients, putting them at increased risk of developing cancer.

29 Apr 2010

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.

29 Apr 2010

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.

29 Apr 2010

DFine granted US patent relating to StabiliT Vertebral Augmentation System

DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that the United States Patent & Trademark Office has issued Patent 7,678,116 relating to the StabiliT® Vertebral Augmentation System. Two additional Notices of Allowance have also been issued with patents expected later this year.

29 Apr 2010

Vascular surgeon successfully bypasses torn aorta

Rhonda Mullen was 38 years old and in perfect health when she suddenly felt a searing pain between her shoulder blades. A few hours later, Mullen was being wheeled into an operating room at Loyola University Hospital for emergency surgery to repair an unusual tear in her aorta, the body's main blood vessel.

29 Apr 2010

SBRT shows promise in treatment of lung, liver and spinal tumors: Clinical experts

Radiosurgical approaches to cancer treatment are showing promise in the treatment of lung, liver, and spinal tumors, according to four leading clinical experts who presented at a symposium in New York earlier this month.

28 Apr 2010

Study examines world-wide use of HSCT

An examination of the world-wide use of hematopoietic stem cell transplantation, which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.

28 Apr 2010

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

28 Apr 2010

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.

28 Apr 2010

DARA Therapeutics collaborates to advance clinical study of KRN5500 for CIPN in cancer patients

DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.

28 Apr 2010

Holtz Children's Hospital expands Pediatric Dialysis Unit

Jackson Memorial Hospital's Holtz Children's Hospital celebrated the renovation of the Pediatric Dialysis Unit Tuesday morning by honoring the Batchelor Foundation, George E. Batchelor, founder; Alonzo Mourning and Zo's Fund for Life; the Jackson Memorial Foundation Guardian Angels; and Alma Hernandez, in memory of her husband Dr. Ismael Hernandez. Together, they raised all of the $800,000 needed for the project.

28 Apr 2010

'Flexi-Scope' test reduces incidence of bowel cancer

A one-off screening test that takes just five minutes could reduce the risk of bowel cancer by one-third and save thousands of lives, UK scientists have said.

28 Apr 2010

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

28 Apr 2010

SI-BONE to present iFuse MIS procedure at WCMISST 2010

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint today announced that iFuse initial post-market clinical experience will be presented at upcoming 2010 minimally invasive spine surgery meetings.

28 Apr 2010

CNN: Hospital markup on supplies can be big

CNN: "When Dr. Linda Galloway learned she needed surgery to save her vision, she scheduled the procedure immediately with her opthamologist. And what an eye-opener it was - when the hospital bill arrived."

28 Apr 2010

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

TYRX, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST, its antibacterial product for the surgical repair of damaged or ruptured soft tissue.

28 Apr 2010

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

Cardiovascular Systems, Inc., has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of CSI's Diamondback 360® System in the coronary arteries. CSI received conditional IDE approval for the ORBIT II study in January 2010.

28 Apr 2010

A bitter pill to swallow

Reporting for Kaiser Health News in collaboration with The Washington Post, Sandra Boodman writes: "When Jere Carpentier learned last year that she had advanced colon cancer -- her third malignancy in a dozen years -- she worried about spending hours in a clinic tethered to an intravenous line, enduring punishing chemotherapy that would make her hair fall out.

28 Apr 2010

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has published results from its Phase II GEMINI study in the Proceedings of the National Academy of Sciences (PNAS). These data, previously presented at the International Symposium on Respiratory Viral Infections in Singapore in 2008, showed human proof of concept with an RNAi therapeutic in a randomized, double blind, placebo-controlled study.

27 Apr 2010

Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research

Tiny, melanin-covered nanoparticles may protect bone marrow from the harmful effects of radiation therapy, according to scientists at Albert Einstein College of Medicine of Yeshiva University who successfully tested the strategy in mouse models.

27 Apr 2010

Medical Procedure News

ECRI Institute's recommendations for controlling CT radiation dose

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

DFine granted US patent relating to StabiliT Vertebral Augmentation System

Vascular surgeon successfully bypasses torn aorta

SBRT shows promise in treatment of lung, liver and spinal tumors: Clinical experts

Study examines world-wide use of HSCT

Coronary artery calcium score helpful for determining intermediate risk of heart disease

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

DARA Therapeutics collaborates to advance clinical study of KRN5500 for CIPN in cancer patients

Holtz Children's Hospital expands Pediatric Dialysis Unit

'Flexi-Scope' test reduces incidence of bowel cancer

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

SI-BONE to present iFuse MIS procedure at WCMISST 2010

CNN: Hospital markup on supplies can be big

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

A bitter pill to swallow

Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS

Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Latest News